Título :	DFT, molecular docking, and ADME/Tox screening investigations of market‑available drugs against SARS‑CoV‑2
Autor :	Araújo, Joabe Lima Sousa, Lucas Aires de Sousa, Alice O. Bastos, Ruan Sousa Santos, Gardênia Taveira Lage, Mateus R. Stoyanov, Stanislav R. Passos, Ionara Nayana Gomes Azevedo, Ricardo Bentes de Rocha, Jefferson Almeida
metadata.dc.identifier.orcid:	https://orcid.org/0000-0002-4806-9192 https://orcid.org/0000-0001-8674-4307
Assunto::	Medicamentos Covid-19 SARS-CoV-2 Docking Teoria do funcional da densidade (DFT)
Fecha de publicación :	2021
Editorial :	Sociedade Brasileira de Química
Citación :	ARAÚJO, Joabe Lima et al. DFT, molecular docking, and ADME/Tox screening investigations of market‑available drugs against SARS‑CoV‑2. Journal of the Brazilian Chemical Society, v. 00, n. 00, p. 1-14, 2021. DOI: https://dx.doi.org/10.21577/0103-5053.20210061. Disponível em: http://static.sites.sbq.org.br/jbcs.sbq.org.br/pdf/2021-0030AR.pdf. Acesso em: 04 maio 2021.
Abstract:	A series of drugs was investigated to determine structural, electronic and pharmacological properties, as well as the molecular affinity for the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The drugs were submitted to density functional theory calculations to optimize structures and predict binding preferences. The optimized geometries were used in molecular docking simulations. In the docking study, the receiver was considered rigid and the drugs flexible. The Lamarckian genetic algorithm with global search and Pseudo-Solis and Wets with local search were adopted for docking. Absorption, distribution, metabolism, excretion and toxicological properties were obtained from the Pre-ADMET online server. In this series, the antiviral atazanavir showed the potential to inhibit the main protease of SARS-CoV-2, based on the free binding energy, inhibition constant, binding interactions and its favorable pharmacological properties. Therefore, we recommend carrying out further studies with in vitro tests and subsequent clinical tests to analyze its effectiveness in the treatment of SARS-CoV-2.
Licença::	(CC BY) - This is an open-access article distributed under the terms of the Creative Commons Attribution License.
DOI:	https://dx.doi.org/10.21577/0103-5053.20210061
Aparece en las colecciones:	Artigos publicados em periódicos e afins UnB - Covid-19

Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.